SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Open-market buys and sells only — the deliberate trades. Zero here doesn’t mean no filings: grants, option exercises and tax withholding (below) are compensation, not market trades.
| Insider | Role | Date | Transaction | Shares | Value |
|---|---|---|---|---|---|
| DE GEUS AART | EXECUTIVE CHAIR, Director | 2026-09-01 | Option exercise 10b5-1 | 24641 | $3.3M |
| DE GEUS AART | EXECUTIVE CHAIR, Director | 2026-09-01 | Open-market sell 10b5-1 | 24641 | $10.3M |
| LEE JANET | GC & Corporate Secretary | 2026-09-01 | Option exercise | 699 | $0 |
| LEE JANET | GC & Corporate Secretary | 2026-09-01 | Tax withholding | 304 | $126K |
| DE GEUS AART | EXECUTIVE CHAIR, Director | 2026-08-31 | Option exercise 10b5-1 | 25000 | $3.4M |
| DE GEUS AART | EXECUTIVE CHAIR, Director | 2026-08-31 | Open-market sell 10b5-1 | 25000 | $11.0M |
| DE GEUS AART | EXECUTIVE CHAIR, Director | 2026-08-31 | J 10b5-1 | 22 | $8K |
| Ellow Michael | Chief Revenue Officer | 2026-08-31 | J | 27 | $10K |
| Ghazi Sassine | PRESIDENT AND CEO, Director | 2026-08-31 | J | 27 | $10K |
| Kankanwadi Sudhindra | Deputy CFO & CAO | 2026-08-31 | J | 27 | $10K |
| DE GEUS AART | EXECUTIVE CHAIR, Director | 2026-08-28 | Option exercise 10b5-1 | 25000 | $3.4M |
| DE GEUS AART | EXECUTIVE CHAIR, Director | 2026-08-28 | Open-market sell 10b5-1 | 25000 | $11.1M |
| LEE JANET | GC & Corporate Secretary | 2026-08-16 | Option exercise | 729 | $0 |
| LEE JANET | GC & Corporate Secretary | 2026-08-16 | Tax withholding | 318 | $134K |
| DE GEUS AART | EXECUTIVE CHAIR, Director | 2026-06-15 | Option exercise | 449 | $0 |
| DE GEUS AART | EXECUTIVE CHAIR, Director | 2026-06-15 | Tax withholding | 156 | $71K |
| Ellow Michael | Chief Revenue Officer | 2026-06-15 | Option exercise | 4048 | $0 |
| Ellow Michael | Chief Revenue Officer | 2026-06-15 | Tax withholding | 2007 | $912K |
| Ellow Michael | Chief Revenue Officer | 2026-06-15 | Option exercise | 1080 | $0 |
| Ellow Michael | Chief Revenue Officer | 2026-06-15 | Tax withholding | 536 | $244K |
Fiscal period ending 2025-10-31 versus 2024-10-31 — view filing on EDGAR →
The Ansys acquisition closed, eliminating pre-close M&A uncertainties but replacing them with $13.5B in realized debt, integration execution risk, and magnified operational exposure at scale. Concurrent worsening across competition, macro/tariff, legal, and supply chain themes — including a securities class action, disclosed foundry customer losses, and Design IP segment underperformance — adds meaningful breadth to the deteriorating side. The net picture is mixed but tilts toward incremental worsening given the volume and specificity of new adverse disclosures.
10 company-specific · 5 eased/removed · 1 common-mode
New disclosure of active securities class action litigation against company and officers alleging material misstatements regarding Design IP segment performance. Specific, named claims create material legal and reputational risk.
We or our directors or officers are subject to litigation proceedings, which are expensive, could divert management attention and harm our business. We are subject to legal claims or regulatory…
Added concrete operational impact: enhanced denied party screening causing elongated transaction cycles. Broadened scope to include sanctions/trade restrictions. Escalated language from "do not materially impact" to "may adversely impact."
We are subject to governmental export and import requirements that could subject us to liability and restrict our ability to sell our products and services, which could impair our ability to compete…
Added concrete example: "challenges with a major foundry customer negatively impacted our financial results for fiscal year 2025." This escalates from generic risk to disclosed material adverse impact on actual results.
Consolidation among our customers and within the industries in which we operate, as well as our dependence on a relatively small number of large customers, may negatively impact our operating…
Merger now completed; debt incurred ($13.5B disclosed). Risk shifted from prospective to realized, with specific debt amount quantified, escalating the concrete financial burden.
Our significant debt may limit our financial flexibility. We have incurred a substantial amount of debt in connection with the Ansys Merger, including the Senior Notes and the $4.3 billion term loan.…
Removed generic macro risks; added specific sector weakness in industrial, automotive, consumer electronics with actual business impact disclosed.
The growth of our business depends primarily on the semiconductor and electronics industries. The growth of the EDA industry as a whole and our sales in our Design Automation and Design IP segments…
New disclosure of Design IP segment underperformance and resource reallocation to address it, plus explicit acknowledgment that reallocation efforts may not succeed or generate expected returns.
We operate in highly competitive industries, and if we do not continue to meet our customers’ demand for innovative technology at lower costs, our products may not be competitive or may become…
Added specific channel partner compliance risk and expanded sanctions/tariff language. Escalates geopolitical and regulatory exposure substantively.
Business Operations Risks The global nature of our operations exposes us to increased risks and compliance obligations. We derive roughly half of our revenue from sales outside the United States, and…
New explicit reference to "workforce" cost control and "business transformation initiatives" signals restructuring activity not previously disclosed in risk factors.
Our operating results may fluctuate in the future, which may adversely affect our stock price. Our operating results are subject to quarterly and annual fluctuations, which may adversely affect our…
Ansys Merger completed; new risk language on benefit realization, magnified risks at scale, and outbound investment restrictions added.
We may not realize the potential financial or strategic benefits of the transactions we complete, including the Ansys Merger, or find suitable target businesses and technology to acquire.…
Added production scaling and yield challenges as new supply risk; replaced specific inflation/semiconductor concerns with vague macroeconomic reference; added tariff exposure to margins.
Our hardware products, which primarily consist of prototyping and emulation systems, subject us to distinct risks. The growth in sales of our hardware products subjects us to risks, including, but…
Removal of Ansys Merger risk factors indicates deal completion or abandonment. Material change resolving significant M&A and debt-related uncertainties disclosed last year.
Risks Related to the Ansys Merger • We may fail to complete the Ansys Merger or may not complete it on the terms described herein or in our other filings with the SEC. • The Ansys Merger is…
Removal of material liquidity and debt risk tied to pending Ansys Merger. Merger likely did not close or was abandoned, eliminating disclosed financing and capital structure concerns.
Liquidity requirements in our U.S. operations may require us to raise cash in uncertain capital markets, which could negatively affect our financial condition. We expect that the pending Ansys Merger…
Removal of $1.5B termination fee risk and merger completion uncertainty materially eases risk. Merger either completed or abandoned, eliminating contingent liability.
Risks Related to the Ansys Merger We may fail to complete the Ansys Merger or may not complete it on the terms described herein or in our other filings with the SEC. It is currently anticipated that…
Removal of material Ansys Merger regulatory approval risk indicates deal closed or abandoned. Either outcome materially resolves prior uncertainty about deal completion, conditions, and divestitures.
The Ansys Merger is subject to the receipt of governmental approvals that may impose conditions that could have an adverse effect on us or, if not obtained, could prevent completion of the Ansys…
Removal of Ansys merger integration risk indicates successful completion or resolution of material M&A uncertainty that previously posed significant business and financial risk.
Failure to realize the benefits expected from the Ansys Merger could adversely affect our business, operating results and financial condition. The anticipated benefits we expect from the Ansys Merger…
New specific disclosure of 2025 U.S. tariffs and trade policy changes; shift from hypothetical to realized macroeconomic impact affecting customer behavior and revenue recognition.
Industry Risks Uncertainty in the macroeconomic environment, and its potential impact on the semiconductor and electronics industries, may negatively affect our business, operating results and…
This is a straightforward earnings release for Synopsys' third fiscal quarter ended July 31, 2026. The Item 2.02 disclosure announces quarterly revenue of $2.477 billion, GAAP EPS of $2.84, and non-GAAP EPS of $3.91, along with raised full-year guidance. The press release is attached as Exhibit 99.1 and contains detailed financial results, segment performance, and forward-looking guidance—all hallmarks of a quarterly earnings announcement.
View raw filing on EDGAR →Janet Lee, serving as General Counsel and Corporate Secretary, is departing her officer role effective December 31, 2026 or upon appointment of a successor. Although she will transition to an advisory role through June 30, 2027, the principal disclosed action is her departure from the General Counsel and Corporate Secretary positions, which are material officer roles. This is a clear executive departure under Item 5.02.
View raw filing on EDGAR →Synopsys issued a press release on May 27, 2026 announcing financial results for its second fiscal quarter ended April 30, 2026. The disclosure explicitly states the press release is attached as Exhibit 99.1, which is the standard format for earnings releases filed under Item 2.02. Quarterly financial results are material to investors' assessment of the company's operational performance.
View raw filing on EDGAR →Synopsys appointed Jesse Cohn to its Board of Directors effective June 1, 2026, pursuant to a Cooperation Agreement with Elliott Investment Management dated May 26, 2026. Mr. Cohn was also appointed to the Corporate Governance and Nominating Committee and received standard director compensation and indemnification arrangements.
View raw filing on EDGAR →